Actinium Pharmaceuticals, Inc.
ATNM
$1.24
$0.010.81%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 11.31M | -23.47M | -33.89M | -34.60M | -41.04M |
| Total Depreciation and Amortization | 873.00K | 836.00K | 821.00K | 819.00K | 815.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -34.75M | 327.00K | 9.19M | 10.38M | 11.61M |
| Change in Net Operating Assets | -92.00K | -568.00K | -704.00K | -1.65M | -2.08M |
| Cash from Operations | -22.66M | -22.88M | -24.58M | -25.04M | -30.69M |
| Capital Expenditure | -584.00K | -106.00K | -104.00K | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -584.00K | -106.00K | -104.00K | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -10.00K | -11.00K | -10.00K | -9.00K | -9.00K |
| Issuance of Common Stock | -- | -- | -- | -- | 4.60M |
| Repurchase of Common Stock | -207.00K | -207.00K | -207.00K | -208.00K | -1.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -217.00K | -218.00K | -217.00K | -217.00K | 4.59M |
| Foreign Exchange rate Adjustments | 19.00K | 17.00K | 6.00K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -23.45M | -23.18M | -24.90M | -25.26M | -26.10M |